Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been assigned a €88.00 ($103.53) target price by equities research analysts at Commerzbank Ag in a research note issued on Monday. The brokerage presently has a “neutral” rating on the stock.

Other equities research analysts also recently issued research reports about the company. HSBC Holdings plc set a €83.00 ($97.65) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research report on Wednesday, April 26th. S&P Global set a €88.00 ($103.53) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a report on Wednesday, May 3rd. J P Morgan Chase & Co set a €106.40 ($125.18) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Wednesday, May 10th. Deutsche Bank AG set a €85.00 ($100.00) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Wednesday, August 2nd. Finally, Kepler Capital Markets set a €95.00 ($111.76) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Wednesday, August 2nd. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of €88.07 ($103.61).

Shares of Fresenius Medical Care AG & Co. KGaA (FME) traded down 1.434% during trading on Monday, reaching €78.024. The company had a trading volume of 4,757 shares. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €70.82 and a 12 month high of €89.07. The stock has a market capitalization of €23.94 billion and a PE ratio of 20.120. The stock’s 50-day moving average price is €83.68 and its 200-day moving average price is €81.11.

COPYRIGHT VIOLATION WARNING: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/08/07/commerzbank-ag-analysts-give-fresenius-medical-care-ag-88-00-price-target.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.